[Current treatment of androgenetic male and female alopecia (with the exception of hormone treatment)].
Various non-hormonal therapies, either prescribed systemically such as certain hair-specific vitamins, or applied via the topical route, such as 2% Minoxidil, permit a normalisation of androgenic hair loss. The trichogenic action of these products should be verified in each individual with a comparative study using a trichogram and a phototrichogram. Any alopecia, be it large or small, may cause aesthetic discomfort. Currently, no medical or cosmetic product can give hope for a discernible and definitive hair regrowth. Only a micrograft reimplantation, hair by hair, produces tangible, aesthetically-denser hair in the bald region.
Bouhanna
P
P
Centre Sabourdaud du Cuir chevelu, Hôpital Saint-Louis, Paris.
D000505:Alopecia / Q000209:etiology* / Q000628:therapy; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000097:blood*; D005260:Female; D006197:Hair / Q000637:transplantation; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000627:therapeutic use; D011379:Prognosis; D014815:Vitamins / Q000627:therapeutic use
D000726:Androgen Antagonists; D000728:Androgens; D014815:Vitamins; D008914:Minoxidil